{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:53:56Z","timestamp":1760885636703,"version":"3.40.4"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"DOI":"10.1093\/toxsci\/kfu132","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T15:49:15Z","timestamp":1404229755000},"page":"377-386","source":"Crossref","is-referenced-by-count":30,"title":["Glucosylceramide and Lysophosphatidylcholines as Potential Blood Biomarkers for Drug-Induced Hepatic Phospholipidosis"],"prefix":"10.1093","volume":"141","author":[{"given":"Kosuke","family":"Saito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Senoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Nakatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiro","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"key\n\t\t\t\t20171013194301_B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/187231207779814292","article-title":"A role for lysosomal phospholipase A2 in drug induced phospholipidosis","volume":"1","year":"2007","journal-title":"Drug Metab. Lett."},{"key":"key\n\t\t\t\t20171013194301_B2","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","year":"2006","journal-title":"FEBS Lett."},{"key":"key\n\t\t\t\t20171013194301_B3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.taap.2006.10.015","article-title":"Biomarkers to monitor drug-induced phospholipidosis","volume":"218","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20171013194301_B4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/138620712799218563","article-title":"Metabolomics: A revolution for novel cancer marker identification","volume":"15","year":"2012","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"key\n\t\t\t\t20171013194301_B5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF02263575","article-title":"Genetic heterogeneity of membrane-bound beta-glucosidase in Gaucher's disease","volume":"4","year":"1981","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20171013194301_B6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"key\n\t\t\t\t20171013194301_B7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/13547500400018570","article-title":"Phenylacetylglycine, a putative biomarker of phospholipidosis: Its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model","volume":"9","year":"2004","journal-title":"Biomarkers"},{"key":"key\n\t\t\t\t20171013194301_B8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*3 Power 3: A flexible statistical power analysis program for the social, behavioral, and biological sciences","volume":"39","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"key\n\t\t\t\t20171013194301_B9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","year":"2013","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20171013194301_B10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737159.8.5.617","article-title":"Metabolomics-based methods for early disease diagnostics","volume":"8","year":"2008","journal-title":"Expert Rev. Mol. Diagn."},{"key":"key\n\t\t\t\t20171013194301_B11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"key\n\t\t\t\t20171013194301_B12","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/MCB.00627-06","article-title":"Lysosomal phospholipase A2 and phospholipidosis","volume":"26","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20171013194301_B13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2008.01.036","article-title":"Gene expression profiling in rat liver treated with compounds inducing phospholipidosis","volume":"229","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20171013194301_B14","doi-asserted-by":"crossref","first-page":"e91806","DOI":"10.1371\/journal.pone.0091806","article-title":"Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects\u2019 gender and age","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171013194301_B15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0016-5085(81)90202-X","article-title":"LIver abnormalities in patients with Gaucher's disease","volume":"80","year":"1981","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171013194301_B16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000469338","article-title":"Functional heterogeneity of periportal and perivenous hepatocytes","volume":"35","year":"1986","journal-title":"Enzyme"},{"key":"key\n\t\t\t\t20171013194301_B17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-2275(20)38976-8","article-title":"Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography","volume":"7","year":"1966","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t20171013194301_B18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0031-6997(25)00049-3","article-title":"Cationic amphiphilic drugs and phospholipid storage disorder","volume":"42","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"key\n\t\t\t\t20171013194301_B19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.1840090504","article-title":"Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients","volume":"9","year":"1989","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171013194301_B20","first-page":"185","article-title":"Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine","volume":"4","year":"1975","journal-title":"CRC Crit. Rev. Toxicol."},{"key":"key\n\t\t\t\t20171013194301_B21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"key\n\t\t\t\t20171013194301_B22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.toxlet.2014.01.008","article-title":"UPLC-MS-based serum metabonomics for identifying acute liver injury biomarkers in Chinese miniature pigs","volume":"225","year":"2014","journal-title":"Toxicol. Lett."},{"key":"key\n\t\t\t\t20171013194301_B23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yjmcc.2013.02.008","article-title":"Global metabolomic analysis of heart tissue in a hamster model for dilated cardiomyopathy","volume":"59","year":"2013","journal-title":"J. Mol. Cel. Cardiol."},{"key":"key\n\t\t\t\t20171013194301_B24","first-page":"136","article-title":"Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats","volume":"1631","year":"2003","journal-title":"Biochem. Biophys. Acta."},{"key":"key\n\t\t\t\t20171013194301_B25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0016-5085(24)05145-X","article-title":"Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical, and electron microscopic studies","volume":"86","year":"1984","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171013194301_B26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"key\n\t\t\t\t20171013194301_B27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: Are there functional consequences","volume":"226","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"key\n\t\t\t\t20171013194301_B28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-104-3-348","article-title":"Amiodarone hepatotoxicity. A clinicopathologic study of five patients","volume":"104","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"key\n\t\t\t\t20171013194301_B29","first-page":"190","article-title":"Origin of plasma lysophosphatidylcholine: Evidence for direct hepatic secretion in the rat","volume":"105","year":"1985","journal-title":"J. Lab. Clin. Med."},{"key":"key\n\t\t\t\t20171013194301_B30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1158\/1078-0432.CCR-08-1059","article-title":"Clinical applications of metabolomics in oncology: A review","volume":"15","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20171013194301_B31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","year":"2013","journal-title":"Lipids Health Dis."},{"key":"key\n\t\t\t\t20171013194301_B32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1091581811430167","article-title":"Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat","volume":"31","year":"2012","journal-title":"Int. J. Toxicol."},{"key":"key\n\t\t\t\t20171013194301_B33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0022-2275(20)38637-5","article-title":"Studies of the pathogenesis of Gaucher's disease: Tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats","volume":"28","year":"1987","journal-title":"J. Lipid Res."},{"key":"key\n\t\t\t\t20171013194301_B34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000112177","article-title":"Clinical aspects of Niemann-Pick type C disease in the adult","volume":"13","year":"1991","journal-title":"Dev. Neurosci."},{"key":"key\n\t\t\t\t20171013194301_B35","first-page":"623","article-title":"Toxicogenomics: The Japanese initiative","volume-title":"Handbook of Toxicogenomics-Strategies and Applications","year":"2005"},{"key":"key\n\t\t\t\t20171013194301_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.02.015","article-title":"Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration","volume":"295","year":"2012","journal-title":"Toxicology"},{"key":"key\n\t\t\t\t20171013194301_B37","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1200\/JCO.2006.08.5571","article-title":"Plasma lysophosphatidylcholine levels: Potential biomarkers for colorectal cancer","volume":"25","year":"2007","journal-title":"J. Clin. Oncol."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/141\/2\/377\/16688196\/kfu132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T16:21:08Z","timestamp":1746289268000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/141\/2\/377\/2510923\/Glucosylceramide-and-Lysophosphatidylcholines-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,10,2]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfu132","relation":{},"ISSN":["1096-0929","1096-6080"],"issn-type":[{"type":"electronic","value":"1096-0929"},{"type":"print","value":"1096-6080"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,10,1]]}}}